Effects of SOD2 genotype, oxidative stress, ER??, and genistein on prostate cance

SOD2 基因型、氧化应激、ER?? 和金雀异黄酮对前列腺癌的影响

基本信息

  • 批准号:
    8115621
  • 负责人:
  • 金额:
    $ 7.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-03-04 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Soy consumption may prevent prostate cancer and be beneficial for patients with this cancer. However, there are contradictory data on the anticancer effects of the soy isoflavone genistein, which has antioxidant properties and can affect cell proliferation and apoptosis of cancer cells through multiple mechanisms, including estrogen receptor-¿ mediation. Genistein also affects the expression of the manganese superoxide dismutase (MnSOD) gene and polymorphisms in this gene are related to risk of prostate cancer. This proposal addresses the hypothesis that the proliferative or inhibitory effects of physiological concentrations of genistein on prostate cancer cells are dependent on their MnSOD genotype and ER-¿ status, as well as on oxidative stress levels. To test this hypothesis, we will determine how genistein acts on prostate cancer cells with different MnSOD variants and ER-¿ expression in a controlled oxidative stress environment with these Specific Aims: (1) Determine the influence of ER-¿ expression on the effects of physiological genistein concentrations on cell proliferation and apoptosis. Physiological concentrations of genistein will be used in controlled ROS environments in cells with specific MnSOD genotypes. (2) Determine the influence of MnSOD genotype on the effects of genistein on cell proliferation and apoptosis of prostate cancer cells expressing different MnSOD variants, while controlling their ER-¿ status and the ROS environment. (3) Determine the effects of genistein on prostate cancer cell proliferation and apoptosis at varying input levels of reactive oxygen species (O2.-), while controlling ER-¿ status and MnSOD genotype. The results of this proposal will provide preliminary data for an R01 application for further studies in animal models relevant to soy consumption in therapeutic and chemopreventive settings with a focus on non-linear dose-response relationships contrasting potential benefit with possible harm of genistein.
描述(由申请人提供): 食用大豆可以预防前列腺癌,并对患有这种癌症的患者有益。然而,关于大豆异黄酮的抗癌作用存在矛盾的数据,大豆异黄酮具有抗氧化特性,可以通过多种机制影响癌细胞的细胞增殖和凋亡,包括雌激素受体介导。染料木黄酮还影响锰超氧化物歧化酶(MnSOD)基因的表达,该基因的多态性与前列腺癌的风险有关。这一提议提出了一个假设,即生理浓度的染料木素对前列腺癌细胞的增殖或抑制作用取决于它们的MnSOD基因型和ER-状态,以及氧化应激水平。为了验证这一假设,我们将确定染料木黄酮如何在受控的氧化应激环境中作用于具有不同MnSOD变体和ER-<$表达的前列腺癌细胞,具体目的如下:(1)确定ER-<$表达对生理染料木黄酮浓度对细胞增殖和凋亡的影响。将在具有特定MnSOD基因型的细胞中的受控ROS环境中使用生理浓度的染料木黄酮。(2)确定MnSOD基因型对染料木素对表达不同MnSOD变体的前列腺癌细胞的细胞增殖和凋亡的影响,同时控制其ER-状态和ROS环境。(3)确定染料木黄酮在不同活性氧(O2.-)输入水平下对前列腺癌细胞增殖和凋亡的影响,同时控制ER-β状态和MnSOD基因型。该提案的结果将为R 01应用提供初步数据,用于在治疗和化学预防环境中与大豆消费相关的动物模型中进行进一步研究,重点是将染料木素的潜在益处与可能的危害进行对比的非线性剂量-反应关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAARTEN C BOSLAND其他文献

MAARTEN C BOSLAND的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAARTEN C BOSLAND', 18)}}的其他基金

Effects of SOD2 genotype, oxidative stress, ER??, and genistein on prostate cance
SOD2 基因型、氧化应激、ER?? 和金雀异黄酮对前列腺癌的影响
  • 批准号:
    8236933
  • 财政年份:
    2011
  • 资助金额:
    $ 7.85万
  • 项目类别:
Preventive Activity of Black Raspberries against Prostate Cancer
黑树莓对前列腺癌的预防活性
  • 批准号:
    8101295
  • 财政年份:
    2010
  • 资助金额:
    $ 7.85万
  • 项目类别:
Preventive Activity of Black Raspberries against Prostate Cancer
黑树莓对前列腺癌的预防活性
  • 批准号:
    7963473
  • 财政年份:
    2010
  • 资助金额:
    $ 7.85万
  • 项目类别:
Hormonal Induction Mouse Models of Prostate Cancer
前列腺癌激素诱导小鼠模型
  • 批准号:
    7661989
  • 财政年份:
    2009
  • 资助金额:
    $ 7.85万
  • 项目类别:
Hormonal Induction Mouse Models of Prostate Cancer
前列腺癌激素诱导小鼠模型
  • 批准号:
    7895865
  • 财政年份:
    2009
  • 资助金额:
    $ 7.85万
  • 项目类别:
CLINICAL TRIAL: PROSTATE CANCER CHEMOPREVENTION TRIAL
临床试验:前列腺癌化学预防试验
  • 批准号:
    7718384
  • 财政年份:
    2008
  • 资助金额:
    $ 7.85万
  • 项目类别:
PROSTATE CANCER CHEMOPREVENTION TRIAL
前列腺癌化学预防试验
  • 批准号:
    7605680
  • 财政年份:
    2007
  • 资助金额:
    $ 7.85万
  • 项目类别:
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
根治性前列腺切除术后大豆辅助试验
  • 批准号:
    7093292
  • 财政年份:
    2006
  • 资助金额:
    $ 7.85万
  • 项目类别:
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
根治性前列腺切除术后大豆辅助试验
  • 批准号:
    7919428
  • 财政年份:
    2006
  • 资助金额:
    $ 7.85万
  • 项目类别:
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
根治性前列腺切除术后大豆辅助试验
  • 批准号:
    7487098
  • 财政年份:
    2006
  • 资助金额:
    $ 7.85万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 7.85万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 7.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 7.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 7.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了